Different Bleeding Patterns with the Use of Levonorgestrel Intrauterine System: Are They Associated with Changes in Uterine Artery Blood Flow?
article
OA: hybrid
CC0
⤵ 1 in-corpus citation
AI-generated summary
Levonorgestrel IUS use reduced menstrual blood loss and altered endometrial thickness, with prolonged bleeding associated with decreased uterine artery pulsatility and resistance indices.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: Evaluate if different bleeding patterns associated with the use of the levonorgestrel intrauterine system (LNG-IUS) are associated with different uterine and endometrial vascularization patterns, as evidenced by ultrasound power Doppler analysis. METHODOLOGY: A longitudinal study, with each subject acting as its own control was conducted between January 2010 and December 2012. Healthy volunteers with a history of heavy but cyclic and regular menstrual cycles were enrolled in the study. Ultrasonographic examination was performed before and after six months of LNG-IUS placement: uterine volume, endometrial thickness, and subendometrial and myometrial Doppler blood flow patterns have been evaluated. RESULTS: A total of 32 women were enrolled out of 186 initially screened. At six months of follow-up, all subjects showed a reduction in menstrual blood loss; for analysis, they were retrospectively divided into 3 groups: normal cycling women (Group I), amenorrheic women (Group II), and women with prolonged bleedings (Group III). Intergroup analysis documented a statistically significant difference in endometrial thickness among the three groups; in addition, mean pulsatility index (PI) and resistance index (RI) in the spiral arteries were significantly lower in Group I and Group III compared to Group II. This difference persisted also when comparing--within subjects of Group III--mean PI and RI mean values before and after insertion. CONCLUSIONS: The LNG-IUS not only altered endometrial thickness, but--in women with prolonged bleedings--also significantly changed uterine artery blood flow. Further studies are needed to confirm these results and enable gynecologists to properly counsel women, improving initial continuation rates.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia 1990
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview 2005
- Uterus and endometrium: The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation 1995
Cited by (1)
References (33)
- Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia via openalex
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview via openalex
- Uterus and endometrium: The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation via openalex
- doi:10.1016/s0029-7844(01)01764-1 via openalex
- doi:10.1007/978-1-4612-3746-4_5 via openalex
- doi:10.1016/j.contraception.2008.06.013 via openalex
- doi:10.1016/s1472-6483(10)60963-7 via openalex
- doi:10.1016/j.contraception.2007.01.008 via openalex
- doi:10.1034/j.1600-0412.1999.780810.x via openalex
- doi:10.1016/j.contraception.2010.09.001 via openalex
- doi:10.1016/s0039-128x(00)00177-x via openalex
- doi:10.1093/humrep/17.11.2878 via openalex
- doi:10.1002/uog.2664 via openalex
- doi:10.1016/0010-7824(89)90050-4 via openalex
- doi:10.1093/humrep/15.suppl_3.162 via openalex
- doi:10.1016/0010-7824(88)90035-2 via openalex
- doi:10.1097/aog.0b013e31828c65d8 via openalex
- doi:10.1016/0010-7824(95)00038-c via openalex
- doi:10.1093/humrep/13.5.1218 via openalex
- doi:10.3109/07853899009147248 via openalex
- doi:10.1080/j.1600-0412.1999.780810.x via openalex
- doi:10.1093/humrep/13.12.3379 via openalex
- doi:10.1016/s0015-0282(16)56455-3 via openalex
- doi:10.1016/s0010-7824(96)00189-8 via openalex
- doi:10.1016/j.contraception.2004.07.002 via openalex
- doi:10.1016/s0010-7824(03)00044-1 via openalex
- doi:10.1093/humrep/13.7.1841 via openalex
- doi:10.1016/j.fertnstert.2007.10.004 via openalex
- doi:10.1016/j.fertnstert.2013.01.151 via openalex
- doi:10.1111/j.1471-0528.2000.tb11610.x via openalex
- doi:10.1046/j.1469-0705.1997.10050350.x via openalex
- doi:10.1097/01.ogx.0000175805.90122.af via openalex
- doi:10.1016/j.fertnstert.2006.04.036 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-10T10:39:02.312044+00:00
License: CC0
· commercial use OK